This is the authors' abstract. We don't add key points for this paper.
Further insight into the cellular mechanisms driving IRIS is urgently needed. Understanding the relative contribution of distinct effector and regulatory T-cell subsets, and innate immune components to IRIS is required to inspire future therapeutic approaches.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Martin‐Blondel et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: